Improving clinical trial outcomes in amyotrophic lateral sclerosis

Individuals who are diagnosed with amyotrophic lateral sclerosis (ALS) today face the same historically intransigent problem that has existed since the initial description of the disease in the 1860s — a lack of effective therapies. In part, the development of new treatments has been hampered by an...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Nat Rev Neurol
Hoofdauteurs: Kiernan, Matthew C., Vucic, Steve, Talbot, Kevin, McDermott, Christopher J., Hardiman, Orla, Shefner, Jeremy M., Al-Chalabi, Ammar, Huynh, William, Cudkowicz, Merit, Talman, Paul, Van den Berg, Leonard H., Dharmadasa, Thanuja, Wicks, Paul, Reilly, Claire, Turner, Martin R.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group UK 2020
Onderwerpen:
Review Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7747476/
https://ncbi.nlm.nih.gov/pubmed/33340024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41582-020-00434-z
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items